We focus on the research and development of biopharmaceuticals for Type 2 diabetes.
We aim to grow into a global leader in the sector of biopharmaceutical technologies.
Our offering for Type 2 diabetes is E2HSA
Recombinant exenatide-human serum albumin. Learn More
Recombinant exenatide-human serum albumin. Learn More
-
Explore more
E2HSA
Recombinant Exenatide
——Human Serum Albumin Fusion Protein
-
Explore more
The starter and leader of bio-innovative anti-type Ⅱ diabetes drugs in China.
-
Promote China's biopharmaceutical technology to the forefront of the world!
Responsibility
E2HSA will facilitate major changes in the treatment of diabetes and bring hope to tens of thousands of diabetics.
Explore more
